Sana Biotechnology (SANA)

• Market cap: $1.07B
• 1 day: -2.04%
• 5 days: -2.78%
• 1 month: 36.52%
• 3 months: 24.6%
• 6 months: -15.94%
• Year to date: -8.11%
• 1 year: -5.17%
• 5 years: -78.94%
• 10 years: -89.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Employees: 142